echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > The 13th five year plan for biotechnology innovation was released, and gene sequencing, immunotherapy and AI were named

    The 13th five year plan for biotechnology innovation was released, and gene sequencing, immunotherapy and AI were named

    • Last Update: 2018-05-14
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Source: yaozhi.com May 14, 2018 As mentioned in the "situation and demand" section of the planning, along with the vigorous development of basic research and continuous breakthroughs in technological innovation, the scale of China's biotechnology industry has been growing continuously, maintaining an annual growth rate of about 20%, which has become an important growth point of China's economy, and formed a number of cities, such as Zhangjiang in Shanghai, Binhai in Tianjin, Taizhou pharmaceutical City, Benxi pharmaceutical capital, and Guanggu in Wuhan , Suzhou biological nano Park and other representative specialized high-tech parks, as well as biomedical industry cluster areas with the Yangtze River Delta, Bohai rim and Pearl River Delta as the core In the "development goal" of the plan, it is proposed to improve the original level of biotechnology, build a platform for biotechnology innovation, and strengthen the industrialization of biotechnology Among them, the goal of "strengthening the industrialization of biotechnology" points out that it is necessary to speed up the construction of high-tech industrial park of biotechnology specialization, build 10-20 biomedical professional parks with an output value of more than 10 billion and 5-10 biomedical professional parks with an output value of more than 10 billion 2 Deployment of four key tasks The plan defines four key tasks, including: 1) breakthrough in several cutting-edge key technologies, 2) support the development of key areas, 3) promote the construction of innovation platform, 4) promote the development of biotechnology industry (1) In this part, the plan divides the frontier key technologies into three categories: disruptive technology, frontier cross technology and common key technology The specific technologies involved include: 1) new generation of biological detection technology, 2) new generation of gene operation technology, 3) synthetic biotechnology, 4) brain science and brain like artificial intelligence, 5) microbiome technology, 6) nano biotechnology, 7) biological image technology, 8) biological big data, 9) group technology and 10) process engineering technology (as shown in the figure below) (2) The plan lists seven key areas to support the development of key areas: biomedicine, biochemical industry, biological resources, bioenergy, bio agriculture, bio environmental protection and biosafety The plan proposes to highlight the development of innovative drugs, medical devices and other major products and the future medical development represented by precision, individualization, substitutability or renewability, focus on breaking through key technologies such as new vaccines, antibody preparation and immunotherapy, seize the strategic commanding point of the biomedical industry, and strive to reach 2020 In, China's biopharmaceutical industry as a whole was transformed from "follow-up" to "parallel" and "leading" in some fields (the figure below is a detailed introduction) (3) Promote the construction of innovation platform According to the plan, we should focus on green biological manufacturing, innovative drug research and development, and biomedical engineering We should integrate advantageous scientific research and technology platforms and human resources in areas with advantages in biotechnology innovation resources and industrial clusters, such as Beijing, Tianjin, Hebei and the Yangtze River Delta We should combine innovative enterprises related to biotechnology to form an industrial alliance and jointly establish a biotechnology innovation center (4) The plan for promoting the development of biotechnology industry proposes to speed up the construction of specialized parks Among them, in the area of "gathering area of biomedical professional park", we should select 10-20 advantageous areas with biomedical output value of more than 10 billion yuan, focus on the R & D and industrialization of new chemical drugs, biomedical drugs and medical devices, promote the modernization of traditional Chinese medicine, cultivate innovative enterprises, and expand the international market The following is the full text of the 13th five year plan for Biotechnology Innovation:
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.